Global Nuclear Medicine/Radiopharmaceuticals Market – Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 – 2024

Press Release

Big Market Research provides ‘Global Nuclear Medicine/Radiopharmaceuticals, 2019 Market Research Report’, which is a professional and in-depth study on the current state of the Global Nuclear Medicine/Radiopharmaceuticals Market.

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.

Scope of the Report:

Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine.

Request for a sample copy of this report @

In application, nuclear medicine / radiopharmaceuticals is for treatment oncology, thyroid, cardiology and other dieses. The nuclear medicine / radiopharmaceuticals market is mainly driven by growing demand for treatment cardiology which accounts for nearly 42.19 % of total downstream consumption of Nuclear Medicine / Radiopharmaceuticals in China.

The worldwide market for Nuclear Medicine/Radiopharmaceuticals is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new Big Market Research (BMR) study.

This report focuses on the Nuclear Medicine/Radiopharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

China Isotope & Radiation, Dongcheng, Jaco, Ciaeriar, Advanced Molecular-imaging Solution, Shanghai Atom Kexing.

Global Nuclear Medicine/Radiopharmaceuticals Market stands to gain remarkable proceeds over 2019-2024, as per a recently compiled report Market Segment by Regions, regional analysis covers:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers –



Market Segment by Applications, can be divided into Enterprise




Enquiry Before Buying @

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Nuclear Medicine/Radiopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Nuclear Medicine/Radiopharmaceuticals, with price, sales, revenue and global market share of Nuclear Medicine/Radiopharmaceuticals in 2017 and 2018.

Chapter 3, the Nuclear Medicine/Radiopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Nuclear Medicine/Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Nuclear Medicine/Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Nuclear Medicine/Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Market Following Details Segment by Table of Contents:

1 Market Overview

1.1 Nuclear Medicine/Radiopharmaceuticals Introduction

1.2 Market Analysis by Type

1.2.1 Diagnostic

1.2.2 Therapeutic

1.3 Market Analysis by Applications

1.3.1 Oncology

1.3.2 Thyroid

1.3.3 Cardiology

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico) United States Market States and Outlook (2014-2024) Canada Market States and Outlook (2014-2024) Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Germany Market States and Outlook (2014-2024) France Market States and Outlook (2014-2024) UK Market States and Outlook (2014-2024) Russia Market States and Outlook (2014-2024) Italy Market States and Outlook (2014-2024)

Access Full Summery @

About Us:

Big Market Research has a range of research reports from various publishers across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.

We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.

Contact us:

Mr. Abhishek Paliwal

5933 NE Win Sivers Drive, #205, Portland,

OR 97220 United States

Direct: +1-971-202-1575

Toll Free: +1-800-910-6452

E-mail [email protected]